Probing protein phosphatase substrate binding: Affinity pull-down of ILKAP phosphatase 2C with phosphopeptides

Molecular BioSystems

Volumn 8, Issue 5, 2012, Pages 1452-1460

  Højlys Larsen, Kim B ^a   Sørensen, Kasper K ^a,b   Jensen, Knud J ^b   Gammeltoft, Steen ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANAZOLENE SODIUM; ATM PROTEIN; CELL CYCLE PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; DNA BINDING PROTEIN; FUCHSINE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOPEPTIDE; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2C; PROTEIN KINASE; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; RIBOSOMAL PROTEIN S6 KINASE, 90KDA, POLYPEPTIDE 3; S6 KINASE; TUMOR SUPPRESSOR PROTEIN;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; ENZYME SPECIFICITY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEOMICS; SOLID PHASE SYNTHESIS; STAINING; SYSTEMS BIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE PROTEINS; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, AFFINITY; COS CELLS; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MOLECULAR SEQUENCE DATA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPEPTIDES; PHOSPHOPROTEIN PHOSPHATASES; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTEOMICS; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; ROSANILINE DYES; SOLID-PHASE SYNTHESIS TECHNIQUES; STAINING AND LABELING; SUBSTRATE SPECIFICITY; SYSTEMS BIOLOGY; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84859856421     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/c2mb05478g     Document Type: Article

References (42)

1. T. Hunter Signaling - 2000 and Beyond Cell (Cambridge, Mass.) 2000 100 113 127
2. G. Manning D. B. Whyte R. Martinez T. Hunter S. Sudarsanam The protein kinase complement of the human genome Science 2002 298 1912 1918
3. A. Alonso J. Sasin N. Bottini I. Friedberg I. Friedberg A. Osterman A. Godzik T. Hunter J. Dixon T. Mustelin Protein Tyrosine Phosphatases in the Human Genome Cell (Cambridge, Mass.) 2004 117 699 711
4. D. Barford A. K. Das M. P. Egloff The structure and mechanism of protein phosphatases: Insights into catalysis and regulation Annu. Rev. Biophys. Biomol. Struct. 1998 27 133 164
5. Y. Shi Serine/Threonine Phosphatases: Mechanism through Structure Cell (Cambridge, Mass.) 2009 139 468 484
6. T. Lammers S. Lavi Role of Type 2C Protein Phosphatases in Growth Regulation and in Cellular Stress Signaling Crit. Rev. Biochem. Mol. Biol. 2007 42 437 461
7. A. Stern E. Privman M. Rasis S. Lavi T. Pupko Evolution of the Metazoan Protein Phosphatase 2C Superfamily J. Mol. Evol. 2007 64 61 70
8. C. Leung-Hagesteijn A. Mahendra I. Naruszewicz G. E. Hannigan Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1 EMBO J. 2001 20 2160 2170
9. A. S. Kumar I. Naruszewicz P. Wang C. Leung-Hagesteijn G. E. Hannigan ILKAP regulates ILK signaling and inhibits anchorage-independent growth Oncogene 2004 23 3454 3461
10. S. Tamura S. Toriumi J.-i. Saito K. Awano T.-a. Kudo T. Kobayashi PP2C family members play key roles in regulation of cell survival and apoptosis Cancer Sci. 2006 97 563 567
11. B. Cengiz M. Gunduz H. Nagatsuka L. Beder E. Gunduz R. Tamamura N. Mahmut K. Fukushima M. Al Sheikh Ali Y. Naomoto K. Shimizu N. Nagai Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer Oral Oncol. 2007 43 241 247
12. M. J. Evans B. F. Cravatt Mechanism-Based Profiling of Enzyme Families Chem. Rev. 2006 106 3279 3301
13. M. Bantscheff D. Eberhard Y. Abraham S. Bastuck M. Boesche S. Hobson T. Mathieson J. Perrin M. Raida C. Rau V. Reader G. Sweetman A. Bauer T. Bouwmeester C. Hopf U. Kruse G. Neubauer N. Ramsden J. Rick B. Kuster G. Drewes Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors Nat. Biotechnol. 2007 25 1035 1044
14. T. McAvoy A. C. Nairn Serine/Threonine Protein Phosphatase Assays Curr. Protocol Mol. Biol. 2010 92 18.18.11 18.18.11
15. M. Mandl D. N. Slack S. M. Keyse Specific Inactivation and Nuclear Anchoring of Extracellular Signal-Regulated Kinase 2 by the Inducible Dual-Specificity Protein Phosphatase DUSP5 Mol. Cell Biol. 2005 25 1830 1845
16. F. Liang S. Kumar Z.-Y. Zhang Proteomic approaches to studying protein tyrosine phosphatases Mol. Biosyst. 2007 3 308 316
17. S. Ding T. Y. H. Wu A. Brinker E. C. Peters W. Hur N. Gray P. G. Schultz Synthetic small molecules that control stem cell fate Proc. Natl. Acad. Sci. U. S. A. 2003 100 7632 7637
18. K. Godl J. Wissing A. Kurtenbach P. Habenberger S. Blencke H. Gutbrod K. Salassidis M. Stein-Gerlach A. Missio M. Cotten H. Daub An efficient proteomics method to identify the cellular targets of protein kinase inhibitors Proc. Natl. Acad. Sci. U. S. A. 2003 100 15434 15439
19. D. Krishnamurthy A. M. Barrios Profiling protein tyrosine phosphatase activity with mechanistic probes Curr. Opin. Chem. Biol. 2009 13 375 381
20. M. Brandt J. C. Madsen J. Bunkenborg O. N. Jensen S. Gammeltoft K. J. Jensen On-bead chemical synthesis and display of phosphopeptides for affinity pull-down proteomics ChemBioChem 2006 7 623 630
21. H. Yamaguchi G. Minopoli O. N. Demidov D. K. Chatterjee C. W. Anderson S. R. Durell E. Appella Substrate specificity of the human protein phosphatase 2C delta Wip1 Biochemistry 2005 44 5285 5294
22. S. Shreeram O. N. Demidov W. K. Hee H. Yamaguchi N. Onishi C. Kek O. N. Timofeev C. Dudgeon A. J. Fornace C. W. Anderson Y. Minami E. Appella D. V. Bulavin Wip1 Phosphatase Modulates ATM-Dependent Signaling Pathways Mol. Cell 2006 23 757 764
23. X. Lu D. Bocangel B. Nannenga H. Yamaguchi E. Appella L. A. Donehower The p53-Induced Oncogenic Phosphatase PPM1D Interacts with Uracil DNA Glycosylase and Suppresses Base Excision Repair Mol. Cell 2004 15 621 634
24. X. B. Lu B. Nannenga L. A. Donehower PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints Genes Dev. 2005 19 1162 1174
25. M. Oliva-Trastoy V. Berthonaud A. Chevalier C. Ducrot M.-C. Marsolier-Kergoat C. Mann F. Leteurtre The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase Oncogene 2007 26 1449 1458
26. H. Fujimoto N. Onishi N. Kato M. Takekawa X. Z. Xu A. Kosugi T. Kondo M. Imamura I. Oishi A. Yoda Y. Minami Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase Cell Death Differ. 2006 13 1170 1180
27. U. Doehn S. Gammeltoft S. H. Shen C. J. Jensen p90 ribosomal S6 kinase 2 is associated with and dephosphorylated by protein phosphatase 2C delta Biochem. J. 2004 382 425 431
28. M. Meldal PEGA - A Flow Stable Polyethylene-Glycol Dimethyl Acrylamide Copolymer for Solid-Phase Synthesis Tetrahedron Lett. 1992 33 3077
29. F. I. Auzanneau M. K. Christensen S. L. Harris M. Meldal B. M. Pinto Synthesis and characterization of polyethylene glycol polyacrylamide copolymer (PEGA) resins containing carbohydrate ligands. Evaluation as supports for affinity chromatography Can. J. Chem. 1998 76 1109
30. M. Brandt S. Gammeltoft K. J. Jensen Microwave heating for solid-phase peptide synthesis: General evaluation and application to 15 mer phosphopeptides Int. J. Pept. Res. Ther. 2006 12 349 357
31. K. Larsen M. Brandt K. K. Sørensen S. Gammeltoft K. J. Jensen Solid-phase peptide synthesis as an enabling tool for proteomics Chim. Oggi 2007 25 34 36
32. G. T. Bourne W. D. F. Meutermans P. F. Alewood R. P. McGeary M. Scanlon A. A. Watson M. L. Smythe A backbone linker for BOC-based peptide synthesis and on-resin cyclization: Synthesis of stylostatin 1 J. Org. Chem. 1999 64 3095 3101
33. R. B. Merrifield L. D. Vizioli H. G. Boman Synthesis of the Antibacterial Peptide Cecropin A(1-33) Biochemistry 1982 21 5020 5031
34. Q. Zheng X.-J. Wang GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis Nucleic Acids Res. 2008 36 W358 W363
35. J. Bartek J. Lukas Chk1 and Chk2 kinases in checkpoint control and cancer Cancer Cell 2003 3 421 429
36. X. Lu T.-A. Nguyen S.-H. Moon Y. Darlington M. Sommer L. A. Donehower The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways Cancer Metastasis Rev. 2008 27 123 135
37. M. B. Kastan D.-s. Lim The many substrates and functions of ATM Nat. Rev. Mol. Cell Biol. 2000 1 179 186
38. M. Frödin S. Gammeltoft Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction Mol. Cell. Endocrinol. 1999 151 65 77
39. C. Hauge M. Frödin RSK and MSK in MAP kinase signalling J. Cell Sci. 2006 119 3021 3023
40. M. Frodin C. J. Jensen K. Merienne S. Gammeltoft A Phosphoserine- regulated docking site in the protein kinase RSK2 that recruits and activates PDK1 EMBO J. 2000 19 2924 2934
41. A. Shevchenko H. Tomas J. Havlis J. V. Olsen M. Mann In-gel digestion for mass spectrometric characterization of proteins and proteomes Nat. Protocols 2006 1 2856 2860
42. T. E. Thingholm M. R. Larsen C. R. Ingrell M. Kassem O. N. Jensen TiO2-Based Phosphoproteomic Analysis of the Plasma Membrane and the Effects of Phosphatase Inhibitor Treatment J. Proteome Res. 2008 7 3304 3313